Latest Articles
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - Yahoo Finance
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress Yahoo Finance
Published: Feb. 23, 2026, 1 p.m.
DUO-E Phase III Trial: Durvalumab Plus Olaparib Maintenance in pMMR Endometrial Cancer - Oncodaily
DUO-E Phase III Trial: Durvalumab Plus Olaparib Maintenance in pMMR Endometrial Cancer Oncodaily
Published: Feb. 23, 2026, 6:45 a.m.
National Conference at JIPMER highlights multidisciplinary advances in endometrial cancer care - The New Indian Express
National Conference at JIPMER highlights multidisciplinary advances in endometrial cancer care The New Indian Express
Published: Feb. 23, 2026, 3:05 a.m.
Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? - Oncodaily
Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? Oncodaily
Published: Feb. 22, 2026, 9:38 a.m.
Multidisciplinary care needed for endometrial cancer: JIPMER - DT Next
Multidisciplinary care needed for endometrial cancer: JIPMER DT Next
Published: Feb. 21, 2026, 3:50 p.m.
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer - CancerNetwork
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer CancerNetwork
Published: Feb. 21, 2026, 2:18 p.m.
Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer - MSN
Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer MSN
Published: Feb. 21, 2026, 12:39 p.m.
JIPMER conducts Conference on Endometrial Cancers 2026 - PIB
JIPMER conducts Conference on Endometrial Cancers 2026 PIB
Published: Feb. 21, 2026, 10:05 a.m.
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa
Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa
Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria
Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria
Published: Feb. 18, 2026, 11:46 p.m.
Link copied to clipboard!